Carrick Therapeutics's competitors

Carrick Therapeutics's competitors include TESARO, AVEO Pharmaceuticals, Cascadian Therapeutics and GlycoMimetics
Add company...
Carrick Therapeutics
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments.
TESARO
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
AVEO Pharmaceuticals
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Cascadian Therapeutics
Cascadian Therapeutics, Inc., formerly Oncothyreon Inc., is a clinical-stage biopharmaceutical company.
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Founding Date
Founding Date
2015
Founding Date
2010
Founding Date
2001
Founding Date
2007
Founding Date
2003
Type
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Dublin, IE HQ
Locations
Waltham, US HQ
Locations
Cambridge, US HQ
Locations
Seattle, US HQ
Locations
Rockville, US HQ
Employees
Employees
9 13% increase
Employees
446
Employees
20
Employees
57
Employees
42
Valuation ($)
Valuation ($)
N/A
Valuation ($)
3.3 b
Valuation ($)
338.7 m
Valuation ($)
N/A
Valuation ($)
514.2 m
Twitter followers
Twitter followers
N/A
Twitter followers
1.7 k
Twitter followers
630
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$44.8m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$18.5k (FY, 2016)
Net income
Net income
N/A
Net income
($387.5m) (FY, 2016)
Net income
($26.9m) (FY, 2016)
Net income
($57.7m) (FY, 2016)
Net income
($31.8m) (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles